{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:15:22Z","timestamp":1783332922782,"version":"3.54.6"},"posted":{"date-parts":[[2026,7,2]]},"group-title":"Biochemistry","reference-count":47,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"Intramural Research Program, NIDDK, NIH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Cell penetrating thyclotides (CPTs) are synthetic molecules that promote highly efficient cellular uptake and endosomal escape of bioactive peptides. While peptides are valuable as medicinal agents, their translation to therapies is often limited by their inability to cross cell membranes. CPTs have a unique combination of chiral tetrahydrofurans and polar sidechains within a molecular scaffold that can be optimized to efficiently deliver peptide cargo into cells. The cellular uptake and endosomal escape of two peptides with anticancer biological activities but low bioavailabilities were remarkably improved after conjugation to a CPT. Using CPTs to overcome barriers to cellular uptake represents a new direction for the intracellular delivery of bioactive molecules, and will accelerate drug development for new medical therapies.<\/jats:p>","DOI":"10.64898\/2026.07.01.735572","type":"posted-content","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:45:23Z","timestamp":1782992723000},"source":"Crossref","is-referenced-by-count":0,"title":["Cell Penetrating Thyclotides Facilitate Efficient Delivery of Bioactive Peptides into Cells"],"prefix":"10.64898","author":[{"given":"Gamze","family":"Ayaz","sequence":"first","affiliation":[{"name":"Synthetic Bioactive Molecules Section, Laboratory of Bioorganic Chemistry (LBC), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, 8 Center Drive, Room 404, Bethesda, Maryland 20892, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Synthetic Bioactive Molecules Section, Laboratory of Bioorganic Chemistry (LBC), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, 8 Center Drive, Room 404, Bethesda, Maryland 20892, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsha","family":"Amarasekara","sequence":"additional","affiliation":[{"name":"Synthetic Bioactive Molecules Section, Laboratory of Bioorganic Chemistry (LBC), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, 8 Center Drive, Room 404, Bethesda, Maryland 20892, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Clausse","sequence":"additional","affiliation":[{"name":"Synthetic Bioactive Molecules Section, Laboratory of Bioorganic Chemistry (LBC), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, 8 Center Drive, Room 404, Bethesda, Maryland 20892, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Tran","sequence":"additional","affiliation":[{"name":"Microscopy Core Facility, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland 20892, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc","family":"Liv\u00e1k","sequence":"additional","affiliation":[{"name":"Laboratory of Genome Integrity Flow Cytometry Core, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland 20892, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kruhlak","sequence":"additional","affiliation":[{"name":"Microscopy Core Facility, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health, Bethesda, Maryland 20892, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Appella","sequence":"additional","affiliation":[{"name":"Synthetic Bioactive Molecules Section, Laboratory of Bioorganic Chemistry (LBC), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, 8 Center Drive, Room 404, Bethesda, Maryland 20892, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026070602300816000_2026.07.01.735572v1.1","doi-asserted-by":"crossref","unstructured":"Y. Tian , M. V. Tirrell , J. L. LaBelle , Harnessing the therapeutic potential of biomacromolecules through intracellular delivery of nucleic acids, peptides, and proteins. Adv. Healthcare Mater. 11, 2102600 (2022).","DOI":"10.1002\/adhm.202102600"},{"key":"2026070602300816000_2026.07.01.735572v1.2","doi-asserted-by":"crossref","first-page":"15465","DOI":"10.1039\/D4NR02093F","article-title":"Intracellular delivery strategies using membrane-interacting peptides and proteins","volume":"16","year":"2024","journal-title":"Nanoscale"},{"key":"2026070602300816000_2026.07.01.735572v1.3","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2272-7_3"},{"key":"2026070602300816000_2026.07.01.735572v1.4","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1039\/D2BM01348G","article-title":"Recent advances in the intracellular delivery of macromolecule therapeutics","volume":"10","year":"2022","journal-title":"Biomater. Sci"},{"key":"2026070602300816000_2026.07.01.735572v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.06.008"},{"key":"2026070602300816000_2026.07.01.735572v1.6","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.8b00799"},{"key":"2026070602300816000_2026.07.01.735572v1.7","doi-asserted-by":"crossref","first-page":"e202400274","DOI":"10.1002\/cmdc.202400274","article-title":"Enhancing Targeted Drug Delivery through Cell-Specific Endosomal Escape","volume":"19","year":"2024","journal-title":"ChemMedChem"},{"key":"2026070602300816000_2026.07.01.735572v1.8","doi-asserted-by":"crossref","unstructured":"S. Zhai , T. Liu , S. Lin , D. Li , H. Liu , X, Yao , T. Hou , Artificial intelligence in peptide-based drug design. Drug Discov. Today 30, 104300 (2025).","DOI":"10.1016\/j.drudis.2025.104300"},{"key":"2026070602300816000_2026.07.01.735572v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.10.003"},{"key":"2026070602300816000_2026.07.01.735572v1.10","doi-asserted-by":"crossref","first-page":"13581","DOI":"10.1021\/jacs.5c17859","article-title":"Macrocyclic peptides containing an imidazopyridinium (IP+) unit display enhanced passive cell permeability","volume":"148","year":"2026","journal-title":"J. Am. Chem. Soc"},{"key":"2026070602300816000_2026.07.01.735572v1.11","doi-asserted-by":"crossref","first-page":"14633","DOI":"10.1021\/jacs.4c01920","article-title":"Synthesis of membrane-permeable macrocyclic peptides via imidazopyridinium grafting","volume":"146","year":"2024","journal-title":"J. Am. Chem. Soc"},{"key":"2026070602300816000_2026.07.01.735572v1.12","doi-asserted-by":"publisher","DOI":"10.1039\/C4CS00246F"},{"key":"2026070602300816000_2026.07.01.735572v1.13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/acs.accounts.5c00775","article-title":"Spherical nucleic acids: turning synthetic advances and fundamental discovery into translational breakthroughs in chemistry, materials development, biology, and medicine","volume":"59","year":"2026","journal-title":"Acc. Chem. Res"},{"key":"2026070602300816000_2026.07.01.735572v1.14","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c06564"},{"key":"2026070602300816000_2026.07.01.735572v1.15","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1039\/D4CC05214E","article-title":"Endosomolytic peptides enable the cellular delivery of peptide nucleic acids","volume":"60","year":"2024","journal-title":"Chem. Commun"},{"key":"2026070602300816000_2026.07.01.735572v1.16","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.9b00033"},{"key":"2026070602300816000_2026.07.01.735572v1.17","first-page":"545","article-title":"Peptoid origins","volume":"96","year":"2010","journal-title":"Pept. Sci."},{"key":"2026070602300816000_2026.07.01.735572v1.18","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1021\/ja8001716","article-title":"A polymeric domain that promotes cellular internalization","volume":"130","year":"2008","journal-title":"J. Am. Chem. Soc"},{"key":"2026070602300816000_2026.07.01.735572v1.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.4.1517"},{"key":"2026070602300816000_2026.07.01.735572v1.20","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300236"},{"key":"2026070602300816000_2026.07.01.735572v1.21","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.0c02109"},{"key":"2026070602300816000_2026.07.01.735572v1.22","doi-asserted-by":"crossref","unstructured":"L. M. Moreno-Vargas , D. Prada-Gracia , Exploring the chemical features and biomedical relevance of cell-penetrating peptides. Int. J. Mol. Sci. 26, 59 (2025).","DOI":"10.3390\/ijms26010059"},{"key":"2026070602300816000_2026.07.01.735572v1.23","doi-asserted-by":"crossref","unstructured":"K. Stillger , I. Neundorf , Cell-permeable peptide-based delivery vehicles useful for subcellular targeting and beyond. Cell. Signal. 109, 110796 (2023).","DOI":"10.1016\/j.cellsig.2023.110796"},{"key":"2026070602300816000_2026.07.01.735572v1.24","doi-asserted-by":"crossref","unstructured":"D. T. Nguyen , M. Desgagn\u00e9 , A. Laniel , C. Lavoie , P. Boudreault , Diversity-oriented synthesis of second generation guanidinium-rich transporters toward cell-selective penetration. Bioorg. Chem. 154, 108041 (2025).","DOI":"10.1016\/j.bioorg.2024.108041"},{"key":"2026070602300816000_2026.07.01.735572v1.25","doi-asserted-by":"crossref","first-page":"e05780","DOI":"10.1016\/j.heliyon.2020.e05780","article-title":"SialoPen peptides are new cationic foldamers with remarkable cell permeability","volume":"6","year":"2020","journal-title":"Hyliyon"},{"key":"2026070602300816000_2026.07.01.735572v1.26","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1002\/anie.200700301","article-title":"Development and biological assessment of fully water-soluble helical aromatic amide foldamers","volume":"46","year":"2007","journal-title":"Angew. Chem. Int. Ed"},{"key":"2026070602300816000_2026.07.01.735572v1.27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1248\/yakushi.18-00179-3","article-title":"Peptide foldamers: structural control and cell-penetrating ability","volume":"139","year":"2019","journal-title":"Yakugaku Zasshi"},{"key":"2026070602300816000_2026.07.01.735572v1.28","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acsmedchemlett.6b00303","article-title":"Turning a substrate peptide into a potent inhibitor for the histone methyltransferase SETD8","volume":"7","year":"2016","journal-title":"ACS Med. Chem. Lett"},{"key":"2026070602300816000_2026.07.01.735572v1.29","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.apsb.2021.06.010","article-title":"Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression","volume":"11","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"2026070602300816000_2026.07.01.735572v1.30","doi-asserted-by":"crossref","unstructured":"L. Xu , L. Zhang , J. Sun , X. Hu , D. V. Kalvakolanu , H. Ren , B. Guo , Roles for the methyltransferase SETD8 in DNA damage repair. Clin. Epigenetics 14, 34 (2022).","DOI":"10.1186\/s13148-022-01251-5"},{"key":"2026070602300816000_2026.07.01.735572v1.31","doi-asserted-by":"crossref","unstructured":"C. Milite , A. Feoli , M. Viviano , D. Rescigno , A. Cianciulli , A. C. Balzano , A. Mai , S. Castellano , G. Sbardella , The emerging role of lysine methyltransferase SETD8 in human diseases. Clin. Epigenetics 8, 102 (2016).","DOI":"10.1186\/s13148-016-0268-4"},{"key":"2026070602300816000_2026.07.01.735572v1.32","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/cmdc.201600272","article-title":"Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors","volume":"11","year":"2016","journal-title":"ChemMedChem"},{"key":"2026070602300816000_2026.07.01.735572v1.33","doi-asserted-by":"crossref","unstructured":"F. Russano , M. Sturlese , L. Dall\u2019Olmo , F. Callegarin , D. Brugnolo , P. Del Fiore , V. Patti , A. Purpura , S. Moro , M. Rastrelli , S. Mocellin , MDM2 in tumor biology and cancer therapy: a review of current clinical trials. Int. J. Mol. Sci. 27, 99 (2026).","DOI":"10.3390\/ijms27010099"},{"key":"2026070602300816000_2026.07.01.735572v1.34","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.123.001026"},{"key":"2026070602300816000_2026.07.01.735572v1.35","doi-asserted-by":"crossref","unstructured":"H. Hou , D. Sun , X. Zhang , The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors. Cancer Cell Int. 19, 216 (2019).","DOI":"10.1186\/s12935-019-0937-4"},{"key":"2026070602300816000_2026.07.01.735572v1.36","doi-asserted-by":"crossref","unstructured":"A. Burgess , K. M. Chia , S. Haupt , D. Thomas , Y. Haupt , E. Lim , Clinical Overview of MDM2\/X-targeted therapies. Front. Oncol. 6, 7 (2016).","DOI":"10.3389\/fonc.2016.00007"},{"key":"2026070602300816000_2026.07.01.735572v1.37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.18632\/oncotarget.248","article-title":"Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture","volume":"2","year":"2011","journal-title":"Oncotarget"},{"key":"2026070602300816000_2026.07.01.735572v1.38","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2955"},{"key":"2026070602300816000_2026.07.01.735572v1.39","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2780"},{"key":"2026070602300816000_2026.07.01.735572v1.40","doi-asserted-by":"crossref","unstructured":"R. Li , P. Zatloukalova , P. Muller , M. Gil-Mir , S. Kote , S. Wilkinson , A. J. Kemp , L. Hernychova , Y. Wang , K. L. Ball , K. Tao , T. Hupp , B. Vojtesek , The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276. Cell Mol. Biol. Lett. 25, 41 (2020).","DOI":"10.1186\/s11658-020-00233-w"},{"key":"2026070602300816000_2026.07.01.735572v1.41","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.42"},{"key":"2026070602300816000_2026.07.01.735572v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-021-00858-8"},{"key":"2026070602300816000_2026.07.01.735572v1.43","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s42255-022-00583-z","article-title":"Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia","volume":"4","year":"2022","journal-title":"Nat. Metab"},{"key":"2026070602300816000_2026.07.01.735572v1.44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1021\/bc800416f","article-title":"Protein delivery with transportans is mediated by caveolae rather than flotillin-dependent pathways","volume":"20","year":"2009","journal-title":"Bioconjugate Chem"},{"key":"2026070602300816000_2026.07.01.735572v1.45","doi-asserted-by":"publisher","DOI":"10.1021\/jo501101s"},{"key":"2026070602300816000_2026.07.01.735572v1.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.10.016"},{"key":"2026070602300816000_2026.07.01.735572v1.47","doi-asserted-by":"publisher","DOI":"10.1021\/jm501092z"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.07.01.735572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:30:40Z","timestamp":1783330240000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.07.01.735572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":47,"URL":"https:\/\/doi.org\/10.64898\/2026.07.01.735572","relation":{},"subject":[],"published":{"date-parts":[[2026,7,2]]},"subtype":"preprint"}}